L 691121
Alternative Names: L 691121 001XLatest Information Update: 30 Jul 1994
At a glance
- Originator Merck & Co
- Class Class III antiarrhythmics
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias